It is the first time in the industry that a self-contained implantable medical device is capable of generating its own energy when operated.
An investment of € 8.2 M will be used for the construction of a 650 sqm controlled atmosphere area on the Rovipharm site.
New paracetamol active ingredient production unit in Roussillon | Investment in US R and D Laboratory | Successful installation of GMP vertical...
GTP Bioways will manufacture clinical batches of the vaccine in Toulouse, France.
The OPTI-STEM project aims to optimize the production of MSCs in order to democratize access to cell therapy in France and Europe.
La French Care is a movement that brings together private and public players in the French Healthcare sector to create a more open and innovative...
French Tech Next40/120 is a support program dedicated to French late-stage start-ups.
Additionally, Triple Ring will make an investment in the One Health Group.
The round is led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors, Elaia and IRDI Capital Investissement.
